View 
FILTERS (0)
* Not connected to ResearchPool

MORE FILTERS

  
reports
Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vital Signs: Actionable charts

In this product we rank the most positive and negative domestic stocks, filter the symbols by market-cap and trading volume, and then divide the companies into sectors and groups. We then manually look through charts leadership/changes, bottoms-up/top-down ideas, short-term patterns that may have long-term significance, etc. We believe you will find this product valuable as significant price and relative moves begin in the daily charts.

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Zimmer Biomet Holdings, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 11 March 2025 in which we reassessed the appropriateness of the ratings in the...

Moody's Ratings assigns Baa2 rating to Zimmer's new senior unsecured n...

Moody's Ratings (Moody's) assigned a Baa2 rating to Zimmer Biomet Holdings, Inc. ("Zimmer") proposed $3 billion senior unsecured notes. At the same time, we assigned a (P)Baa2 rating to Zimmer's senior unsecured shelf registration. There are no changes to the existing Baa2 senior unsecured rating. T...

Moody's Ratings says Zimmer's acquisition of Paragon 28, Inc. raises l...

Moody's Ratings (Moody's) said that the announcement by Zimmer Biomet Holdings, Inc. ("Zimmer") that it intends to acquire Paragon 28, Inc. ("Paragon 28") will raise leverage but will aid in future growth and further diversify the company's overall business. There is no impact on Zimmer's ratings in...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Booster Shots: Attractive bottom-fishing stocks

For investors looking for bottom-fishing candidates; stocks that are breaking downtrends, exhibiting ascending reaction lows, and showing stabilizing relative strength.

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Compass: Weekly Equity Strategy

S&P 500 Testing Prior Breakout Level DeepSeek appears to have turned the chatbot market upside-down, putting pressure on AI-linked stocks. While the dust has yet to settle, the good news is that the selloff has been largely contained to these AI-linked stocks. The rest of the market did not seem to care; the equal-weighted S&P 500 was roughly flat yesterday. Additionally, market dynamics remain healthy, with Treasury yields, the U.S. dollar (DXY), and WTI crude oil continuing to move lower, and...

Moody's Ratings assigns Baa2 to Zimmer Biomet Holdings, Inc.'s new uns...

Moody's Ratings (Moody's) assigned Baa2 rating to the new senior unsecured notes issued by Zimmer Biomet Holdings, Inc. ("Zimmer"). There are no changes to the existing ratings of Zimmer, including the Baa2 senior unsecured notes ratings. The outlook remains unchanged at stable. Proceeds from the ...

Moody's Ratings assigns Baa2 to Zimmer Biomet Holdings, Inc.'s new uns...

Moody's Ratings (Moody's) assigned Baa2 rating to the new senior unsecured notes issued by Zimmer Biomet Holdings, Inc. ("Zimmer"). There are no changes to the existing ratings of Zimmer, including the Baa2 senior unsecured notes. The outlook remains unchanged at stable. Proceeds from the offering...

Zimmer Biomet Holdings, Inc.: Update to credit analysis

Our credit view of this issuer reflects its healthy EBITDA margin and strong free cash flow generation, constrained by its pricing pressure from competition.

Moody's Ratings announces completion of a periodic review of ratings o...

Moody's Ratings (Moody's) has completed a periodic review of the ratings of Zimmer Biomet Holdings, Inc. and other ratings that are associated with this issuer. The review was conducted through a rating committee held on 26 June 2024 in which we reassessed the appropriateness of the ratings in the ...

Dave Nicoski ... (+2)
  • Dave Nicoski
  • Ross LaDuke

Vermilion Short Shots: Technically Vulnerable Stocks

Short Shots is a collection of technically vulnerable charts culled from the Negative Inflecting and Toppy columns within our Weekly Compass report or from various technical screening processes. The charts contained in this report have developed concerning technical patterns that suggest further price deterioration is likely. For these reasons Short Shots can also be a great source of ideas for investors interested in short-selling candidates.

Zimmer Biomet Holdings Inc: 1 director

A director at Zimmer Biomet Holdings Inc sold 12,857 shares at 114.691USD and the significance rating of the trade was 90/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two y...

Moody's assigns Baa2 to Zimmer Biomet Holdings, Inc. new senior unsecu...

Moody's Investors Service ("Moody's") assigns Baa2 rating to Zimmer Biomet Holdings, Inc. ("ZBH") or ("Zimmer Biomet") proposed $500 million senior unsecured notes.  There are no changes to the existing Baa2 senior unsecured ratings. The outlook remains unchanged at stable. Proceeds from the new $...

Loading...
New interest

Save your current filters as a new Interest

Please enter a name for this interest

Email alerts

Would you like to receive real-time email alerts when a new report is published under this interest?

Save This Search

These search results will show up under 'Saved searches' in the left panel

Please enter a name for this saved search

ResearchPool Subscriptions

Get the most out of your insights

Get in touch